Skip to main content
Comprehensive Psychoneuroendocrinology logoLink to Comprehensive Psychoneuroendocrinology
. 2026 Jun 23;27:100359. doi: 10.1016/j.cpnec.2026.100359

Are psychosocial factors and menopause symptoms related to hair cortisol concentrations among midlife Latinas? Results from the Menopausia, Salud, Corazón pilot study

Christian A Long a, Valentina Marginean b, Latesha K Harris c, Chongben Zhang d, Yamnia I Cortés b,⁎
PMCID: PMC13320539  PMID: 42388907

Abstract

Objective

To explore the relationship between psychosocial factors, menopause symptoms, and hair cortisol concentrations (HCC) among midlife Latinas in a community-engaged pilot study.

Methods

A cross-sectional analysis was conducted using baseline data of 45 midlife Latinas enrolled in Menopausia, Salud, Corazón, a community-based cardiovascular disease risk reduction pilot study. Participants completed self-report measures to assess psychosocial factors (e.g., perceived stress, everyday discrimination, resiliency) and menopause symptoms. Cortisol was extracted from hair samples using Salimetrics kit 1-3002 and ran in duplicates (pg/mg). HCC were log-transformed and linear regression models adjusting for age and education were performed to explore the effects of psychosocial factors and menopause symptoms on HCC.

Results

Participants were on average aged 47.4 ± 4.5 years, 48.9% had a high school education or higher, and 98% were born outside the continental United States. The median HCC was 4.3 pg/mg (2.7- 8.2 pg/mg). After adjusting for age and education, experiencing any vasomotor symptoms (VMS) in the previous two weeks was associated with higher HCC (β[SE]: 0.59[0.26], p = 0.03). When additionally adjusting for perceived stress, there was a suggestive association between VMS and HCC (β[SE]: 0.49[0.27], p = 0.08).

Conclusions

Hair cortisol may capture aspects of chronic stress exposure, although its interpretation remains complex. Few studies have assessed HCC in midlife women, particularly Latinas. Though exploratory, our findings suggest a possible association between VMS and HCC that should be studied further. Future research with larger sample sizes and multiple time points is necessary to confirm these results and explore the use of hair cortisol in menopause research.

Clinical trial registration

Prospectively registered, NCT04313751 (03/19/2020), Protocol version 1.0.

Keywords: Cortisol, Hispanic/Latina, Menopause, Midlife, Stress, Vasomotor symptoms

Highlights

  • •

    Study contributes data on HCC among midlife Latinas, an understudied population.

  • •

    VMS were associated with higher HCC, but not after accounting for perceived stress.

  • •

    Findings underscore the need for larger, longitudinal studies.

1. Introduction

Cortisol, a biomarker of hypothalamic-pituitary-adrenal (HPA) axis activity that is commonly associated with physiological responses to stress [1], may increase during the menopause transition (MT) [[2], [3], [4]]. Rising cortisol during this window has been associated with reproductive hormone fluctuations [[3], [4], [5]], poor sleep quality [6], physical inactivity [7], depressive symptoms [8,9], obesity [[10], [11], [12]] and higher levels of psychosocial stress [4,10]. Prior research has linked cortisol dysregulation to psychosocial stress and menopause-related symptoms, including vasomotor symptoms (VMS) [[13], [14], [15], [16]].

Hair cortisol concentration (HCC) is an emerging measure of cumulative HPA axis activity that captures longer-term cortisol exposure and may provide insight into physiological stress processes over time [1,2,10,12,17,18]. Unlike salivary or serum cortisol, which reflect short-term fluctuations and require multiple time-sensitive samples [19], HCC offers a less burdensome approach to assessing chronic cortisol levels. In addition, serum cortisol may be invasive and pose additional logistical and financial concerns [20]. Since hair grows at a relatively constant rate at approximately 1 cm per month [21], the assessment of HCC may be a more consistent reflection of total HPA activity over the preceding months [1,2]. Thus, HCC may be a valuable tool to measure long-term concentrations of cortisol during the MT.

Midlife Latina women may be particularly vulnerable to stress-related physiological dysregulation, as they report higher levels of psychosocial stress compared to other populations [22], including exposure to discrimination and socioeconomic stressors [23,24]. These stressors may influence neuroendocrine pathways, including HPA axis activity, and in turn contribute to both psychological and physical health outcomes in adults [13,25,26]. Stress has been related to systemic inflammation, impaired sleep, and a worse diet [10,27]. In addition to perceived stress, other psychosocial factors such as discrimination and resilience may also play important roles in shaping stress-related physiological responses. Perceived discrimination represents a chronic sociocultural stressor that has been linked to dysregulation of the HPA axis, while resilience may buffer the physiological effects of stress [10]. However, these psychosocial factors have been less frequently examined in relation to HCC, particularly among midlife Latina women. Moreover, despite growing interest in cortisol as a biomarker of stress, few studies have examined HCC in Latina populations, and even fewer have explored how psychosocial factors and menopause symptoms jointly relate to HCC. Therefore, the purpose of this exploratory study was to examine the associations between psychosocial factors (perceived stress, discrimination, and resilience), menopause symptoms, and HCC among midlife Latina women. Findings from this study may be useful for investigators considering the use of HCC in their research. In addition, this study can provide a better understanding of biological measures of stress and their associated factors among Latinas during the MT.

2. Materials and methods

2.1. Study design

A cross-sectional analysis was conducted using baseline data from participants enrolled in Menopausia, Salud, Corazón– a pilot study designed to reduce cardiovascular disease (CVD) risk in midlife Latinas. The design and procedures of this pilot study have been previously published [28]. Briefly, this clinical trial was a two-group, randomized repeated measures pilot study to evaluate the feasibility and initial efficacy of a behavioral intervention consisting of 12 weekly sessions of nutrition education [[29], [30], [31]], physical activity [[32], [33], [34]], and coping skills training [35] followed by 3 monthly sessions of continued support. Data were collected at three time points (baseline, 6-month, 12-month) and included an interviewer-administered questionnaire as well as a clinical assessment.

2.2. Sample

Women were recruited between July 2020 and June 2022 from community settings including local businesses, churches, clinics, health fairs, and community-based organizations in North Carolina. Bilingual (English, Spanish) research assistants (RAs) and community health workers facilitated recruitment efforts. In-person and online strategies were also used such as posting flyers in public spaces, attending community events and meetings to share information about the research study, and social media posts. Additional recruitment strategies applied during the COVID-19 pandemic have been published [36].

Eligible participants were women aged 40-60 years who self-identified as Hispanic/Latina, able to understand spoken English or Spanish, were perimenopausal or early postmenopausal (change in menstrual cycle duration or inter-bleeding interval, or no menstrual bleeding in the past 3–24 months), and reported no menopause hormone therapy use in the preceding three months. Women were excluded if they were pregnant or had a prior history of CVD (i.e., heart attack, stroke, coronary heart disease, heart failure). Forty-nine women were enrolled in the pilot study of which 96% (n = 47) agreed to HCC. Two outliers (HCC ≥100 pg/mg) were excluded. Thus, the current study included 45 participants.

2.3. Ethical considerations and trial registration

The Institutional Review Board of The University of North Carolina at Chapel Hill approved the research, and written informed consent was obtained from all participants in their preferred language (English or Spanish). The study was registered at the www.ClinicalTrials.gov registry (NCT04313751).

2.4. Procedures and measures

Data collection took place in private locations such as the Biobehavioral Laboratory of The University of North Carolina at Chapel Hill School of Nursing, the participant's home, or in a private room within a community-based organization familiar to the participant. Bilingual research assistants (RAs) were responsible for collecting participant data, preferably in the morning following an overnight fast (8-12 h). Procedures were performed in the participant's preferred language and questionnaires were available in English and Spanish.

2.4.1. Hair cortisol concentrations

Hair cortisol was collected from the posterior vortex region of the scalp using standardized guidance [37]. Hair was parted horizontally, and a 3 cm sample (diameter about half a pencil) was cut from the deeper layers of hair as close to the scalp as possible. Additionally, it was noted if participants had received any hair treatment, including bleaching, dyeing, or permanent alterations such as a perm or straightening treatment. Samples were packaged in aluminum foil with a string tied towards the proximal end, and stored in a laboratory refrigerator at −20°C until analysis.

HCC were measured at the Biobehavioral Laboratory of the University of North Carolina at Chapel Hill School of Nursing following a standardized protocol. The hair was first cut into three 1 cm segments, weighed, and washed with isopropanol (1.0 mL per 1 cm) on a rotator for 5 min. After drying, the hair was ground to a fine powder in a mixer mill (Retsch MM400; Retscch GmbH, Germany) at 29-30 scale for 25 min. Cortisol was extracted from the ground hair using methanol and an enzyme-linked immunoassay (Salimetrics Assay kit 1-3002, Carlsbad, CA) was used to measure HCC [37, 38]. In brief, this assay has a sensitivity of <0.007 μg/dL, with a detection range of 0.012-3.000 μg/dL (#1-3002, 2024). Cortisol was run in duplicates and we report the average of the duplicates. The cortisol intra-assay % CV was <10% and inter-assay % CV was <15%. The results were expressed as pg/mg, with pg as the cortisol amount and mg as the hair amount. The hair amount is the hair weight after washing two times with isopropanol.

2.4.2. Psychosocial questionnaires

Interviewer-administered questionnaires were employed to collect information about psychosocial factors. These questionnaires included the Perceived Stress Scale-4 (PSS-4) [39], the Everyday Discrimination Scale [40], and the Brief Resilience Scale (BRS) [41]. The PSS-4 is a 4-item questionnaire that uses a 5-point Likert scale to assess the degree to which participants gauge certain situations as stressful in the past month [39,42]. The raw score was calculated by summing the responses, providing a range of 0 (low stress) to 16 (high stress) with good internal consistency (Cronbach's α = 0.82) [42]. The Everyday Discrimination Scale was used to assess the frequency of discriminatory treatment in the daily lives of participants (Cronbach's α > 0.74) [43]. Scores were summed, resulting in a possible overall score of 10 to 60, with higher scores indicating more frequently reported discriminatory encounters [40,43]. The BRS was used to evaluate the ability of each participant to bounce back or recover from stress [44]. Scores were summed and averaged, providing a range of 1 to 5, with higher scores indicating greater resilience [41]. The BRS has demonstrated sufficient reliability (Cronbach's α = 0.83; ICC = 0.69) and validity [41].

2.4.3. Menopause symptoms and sleep disturbances

Menopause symptoms were assessed using a questionnaire previously employed in the Study of Women's Health Across the Nation (SWAN) [45]. Women were asked how many days in the past two weeks they experienced vasomotor symptoms (hot flashes, night sweats), feeling down/depressed, irritability or grouchiness, feeling tense or nervous, forgetfulness, and frequent mood changes. For each symptom, women reported: not at all, 1–5 days, 6–8 days, 9–13 days, or every day. Due to the number of cell sizes with <5 participants, we dichotomized the frequency of each symptom as none versus any. Sleep disturbances in the past two weeks were self-reported using a separate 4-item questionnaire (trouble falling asleep, trouble staying asleep, early morning waking, restlessness) adapted from the Women's Health Initiative Insomnia Rating Scale [46]. Each item was scored using a 5-point Likert scale from 0 to 4, with higher scores indicating greater sleep disturbances.

2.4.4. Covariates

Covariates in this analysis included several sociodemographic factors. Participants self-reported age, Latino sub-group/nationality, and years living in the continental U.S. Participants reported their highest educational attainment (<high school; ≥high school) and financial strain (no difficulty paying for basic necessities; somewhat/very hard paying for basic necessities). Height was measured to the nearest 0.1 cm using a stadiometer, calibrated in 1/8-cm intervals. A Seca 874 scale was used to measure weight to the nearest 0.1 kg. Body mass index (BMI) was computed as weight divided by the square of height (kg/m2). RAs performed waist circumference measurements (at the umbilicus) with a Lufkin tape, following the protocol outlined in the Multi-Ethnic Study of Atherosclerosis [47]. The average of two consecutive waist measurements was used (cm).

2.5. Data analysis

Data were analyzed using SAS 9.4 (SAS Institute Cary, North Carolina). First, descriptive statistics (frequency, mean, standard deviations) were performed to summarize participant characteristics. Next, cortisol values were log-transformed for normality. Simple linear regression was performed to explore each independent variable in relation to HCC. Next, models were adjusted for covariates commonly associated with HCC (e.g., age, marital status, BMI, smoking). Age and education were selected because these two covariates yielded the highest adjusted R2 when included in the models. Given that perceived stress and VMS were most strongly associated with HCC, to evaluate independent associations, the final model included perceived stress, VMS, age, and education. Model assumptions were evaluated using residual diagnostics to assess linearity, normality of residuals, and homoscedasticity; no major deviations were observed. All analyses were two-sided at a 5% level of significance.

3. Results

Table 1 presents participant characteristics. Participants were on average aged 47.4 ± 4.5 years, 48.9% had a high school education or higher, and 53.3% reported difficulty paying for basics. Nearly all participants (98%) were foreign-born, with an average of 18.3 ± 8.6 years residing in the U.S. In terms of psychosocial factors, mean scores were 5.1 ± 3.1 for perceived stress, 13.6 ± 4.5 for perceived everyday discrimination, and 20.6 ± 4.9 for the Brief Resiliency Scale. Over half reported experiencing VMS (66.7%), feeling tense or nervous (62.2%), forgetfulness (62.2%), and mood changes (64.4%) within the past two weeks. Participants were on average obese (BMI 30.4 ± 5.4) [48], with an average waist circumference of 94.8 ± 12.6 cm. The median HCC was 4.3 pg/mg, ranging from 2.7 pg/mg to 8.2 pg/mg. Scatterplots and boxplots illustrating associations are presented in the Supplementary Material.

Table 1.

Participant characteristics.

Variable N = 45
Age, mean (SD) 47.4 (4.5)
Education, n (%)
 Less than high school education 22 (48.9)
 ≥ high school education 23 (51.1)
Years in the U.S, mean (SD) 18.3 (8.6)
Difficulty paying for basics, n (%)
 Not very hard at all 17 (37.8)
 Somewhat/very hard 24 (53.3)
 Refused 4 (8.9)
Body mass index kg/m2, mean (SD) 30.4 (5.4)
Waist circumference (cm), mean (SD) 94.8 (12.2)
Perceived stress scale (10-50), mean (SD) 5.1 (3.1)
Everyday discrimination scale (10-60), mean (SD) 13.6 (4.5)
Brief resilience scale (6-30), mean (SD) 20.6 (4.9)
Menopause symptoms in past 2 weeks
 Vasomotor symptoms 30 (66.7)
 Feeling blue, down, depressed 20 (44.4)
 Irritability or grouchiness 22 (48.9)
 Feeling tense or nervous 28 (62.2)
 Forgetfulness 28 (62.2)
 Frequent mood changes 29 (64.4)
Overall sleep (0-16), mean (SD) 6.8 (4.7)
Cortisol (pg/mg) 4.3 (2.7, 8.2)

Note. cm = centimeters; kg = kilograms; pg/mg = picogram per milligram; SD = standard deviation.

Table 2 presents findings from unadjusted and adjusted linear regression models. In unadjusted models, VMS was significantly associated with higher HCC (β [SE]: 0.63 [0.25], p = 0.01). There was inconclusive evidence on the association between perceived stress and HCC (β [SE]: 0.07 [0.04], p = 0.08). Similarly, there was a non-significant association between feeling tense or nervous and HCC (β [SE]: 0.45 [0.25], p=(0.08). After adjusting for age and education, reporting any vasomotor symptoms remained significantly associated with HCC (β [SE]: 0.59 [0.26], p = 0.03), and there was a non-significant association with perceived stress (β [SE]: 0.08 [0.04], p = 0.07). When we included perceived stress and VMS in the model, VMS was no longer significant (β [SE]: 0.49 [0.27], p = 0.08). No other variables were associated with HCC.

Table 2.

Factors associated with hair cortisol in midlife Latinas.

Variable Model 1 β (SE) P Model 2 β (SE) P Model 3 β (SE) P
Perceived stress scale 0.07 (0.04) 0.08 0.08 (0.04) 0.07 0.05 (0.04) 0.20
Everyday discrimination scale 0.03 (0.03) 0.27 0.03 (0.03) 0.28
Brief resilience scale −0.03 (0.16) 0.84 −0.08 (0.17) 0.63
Menopause symptoms in the past 2 weeks (any versus none)
 Vasomotor symptoms 0.63 (0.25) 0.01 0.59 (0.26) 0.03 0.49 (0.27) 0.08
 Feeling blue, down, depressed 0.34 (0.24) 0.17 0.29 (0.25) 0.26
 Irritability or grouchiness 0.04 (0.25) 0.88 0.006 (0.25) 0.98
 Feeling tense or nervous 0.45 (0.25) 0.08 0.39 (0.27) 0.15
 Forgetfulness 0.39 (0.25) 0.12 0.36 (0.26) 0.18
 Frequent mood changes 0.19 (0.26) 0.46 0.20 (0.27) 0.47
Overall sleep 0.03 (0.03) 0.34 0.03 (0.03) 0.44
Covariates
 Age -- -- 0.01 (0.02) 0.58 0.01 (0.02) 0.60
 Education -- -- −0.03 (0.08) 0.71 −0.04 (0.08) 0.65

Note. Factors were tested in separate models with log-transformed HCC as the outcome. Model 1 is unadjusted; Model 2 adjusts for age and education. Because vasomotor symptoms and perceived stress showed significant or inconclusive associations with HCC in Model 2, Model 3 additionally adjusts for perceived stress to assess whether the association between VMS and HCC is attenuated.

4. Discussion

This pilot study explored the association between psychosocial factors and menopause symptoms with HCC in Latinas during the MT. We found that worsening VMS over two weeks may be associated with a higher HCC. These findings could suggest an underlying aggregation of VMS pathophysiology that lead to compounded HCC over time. These findings are similar to those of other studies that have investigated VMS in relation to cortisol [16,49]. While most of these studies measured salivary or urine cortisol [3,[14], [15], [16]], one study reported that HCC was associated with an increased frequency of daily hot flashes using ambulatory and physiological data [3]. Our findings suggest a potential association between HPA axis activity and vasomotor symptoms, although the direction of this relationship cannot be determined. VMS are believed to result from altered thermoregulatory function in the hypothalamus, which is influenced by fluctuating estrogen levels during the MT [50]. There is evidence that increases in body temperature induce a typical stress response, with the secretion of catecholamines and cortisol, which induce thermoregulatory mechanisms to maintain internal temperature homeostasis [50]. Though findings were not significant when adjusting for perceived stress, they remained pronounced and serve to suggest a possible association that merits further investigation.

It is important to note that perceived stress was not significantly associated with HCC after adjusting for age and education; however, the direction of the association was positive. Perceived stress was higher in our sample than previous studies [10,51], which may be due to a combination of factors regarding our study sample: mostly immigrant Latinas; 53.3% experiencing financial strain; and our study was conducted during the COVID-19 pandemic when people were experiencing higher levels of social isolation and stress. It is also possible that because the PSS-4 measures stress over 4 weeks, and not a 12-week period, it reflects the average cortisol accumulation in hair samples at cross-sections; thus, longer self-report measures for chronic stress should be used to understand the relationship between stress and HCC better. Additionally, other studies have supported these associations between perceived stress and HCC among minoritized groups when controlled for financial strain [52]. Curiously, despite no association with HCC and psychosocial factors, participants in our cohort reported higher perceived everyday discrimination than previously reported literature in other minoritized populations [53].

Participants in our study all self-reported Latina ethnicity; however, participants were racially diverse with varied hair textures. Hair cortisol has been previously shown to vary by hair type, including hair color and texture [10,54]. For example, Moody et al. found that Latina participants with tightly curled hair had higher cortisol levels when compared to more wavy or straight hair [54]. Furthermore, hair type may impact individual preferences in frequency of hair washing, types of hair treatment, and the products utilized that may or may not impact cortisol binding protein at a molecular level [54]. Other studies have theorized that darker hair may have protective factors [55], although this has been contested in other cohort studies [56]. Future studies should consider the impact of hair type, particularly hair texture, including on cortisol concentration.

4.1. Strengths and limitations

There are several limitations and strengths to consider in this analysis. This is an exploratory study with a small sample size, largely conducted in the context of COVID-19 restrictions, which hindered recruitment for the study at large. Given the pilot nature of this study, we conducted a post hoc power analysis based on the observed association between vasomotor symptoms and hair cortisol concentrations. With an estimated small-to-moderate effect size (Cohen's d ≈ 0.34) and a sample size of 45, statistical power was approximately 60% at α = 0.05, indicating limited power to detect modest associations. However, to our knowledge, this is currently the largest ethnically-Latina cohort living in the U.S examining HCC using a Salimetrics assay and the only one examining midlife women [57]. Another limitation of this study is the lack of data on hair-washing practices, which may influence HCC [58]. Additionally, given the cross-sectional design of HCC collection, it is unknown if perceived stress results in worsening menopausal symptoms or vice versa; however, we included perceived stress and VMS in a model to evaluate independent associations. Another limitation is that we were exploring multiple independent variables, increasing the likelihood of Type I error. Nevertheless, our study was exploratory aiming to identify patterns to generate hypotheses for future research utilizing HCC methodology in this population.

The use of HCC was a strength in this investigation since it may reflect consistent cortisol concentration more accurately than urinary or salivary collection [1]. The latter measures may be impacted by sleep patterns, poor adherence to constant sampling, and biological limitations. While all participants (n = 45) denied hair treatment, a potential limitation of hair cortisol is the impact of hair treatments, frequency of hair washing, and chemical exposure [1]; however, the impact of these behaviors has been contested by other longitudinal studies [55,56,59]. As indicated, HCC was obtained using standardized protocol [37] with additional sources indicating no variation in HCC measurements based on where sampled is sourced [60]. As is best practice, samples were tested within a one-year window prior to any potential breakdown in analyte stability [60]. The immunoassay kit utilized in this study has popular use among other studies for hair cortisol measurement [52,61,62]; however, this kit is not validated for hair sampling (#1-3002, 2024). The distribution of HCC among this cohort was comparable to other women of heterogenous ethnicities in previous studies [51]. To our knowledge, this is the first study to examine hair cortisol in an exclusively midlife Latinas navigating the MT [13,25].

5. Conclusions

This study demonstrated the feasibility of measuring hair cortisol concentrations in midlife Latinas. We found a suggestive association between VMS and HCC that should be further evaluated with temporally aligned measures. Although not significant, this is an important finding supporting a potential biological link between stress and VMS. Future longitudinal studies in larger samples are necessary to confirm these results and examine associations between menopause-related factors and HCC.

Disclaimer

The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIMHD, NIH or the Robert Wood Johnson Foundation.

Funding

This study was funded by the National Institutes of Health and the National Institute of Minority Health and Health Disparities (K23MD014767, PI: Cortés). At the time of submission, Latesha K. Harris, PhD, RN, was supported by the Robert Wood Johnson Foundation Health Policy Research Scholars Program and the National Institute on Nursing Research (T32NR007091; PI: Santacroce & Kneipp). A version of this manuscript was presented at the 2022 Menopause Society Annual Meeting.

CRediT authorship contribution statement

Christian A. Long: Conceptualization, Methodology, Writing – original draft, Writing – review & editing. Valentina Marginean: Methodology, Writing – original draft, Writing – review & editing. Latesha K. Harris: Data curation, Writing – original draft, Writing – review & editing. Chongben Zhang: Methodology, Writing – original draft, Writing – review & editing. Yamnia I. Cortés: Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Supervision, Writing – original draft, Writing – review & editing.

Declaration of competing interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgements

The authors would like to thank the University of North Carolina at Chapel Hill (UNC-CH) School of Nursing Biobehavioral Laboratory for their assistance and insights throughout this pilot study. We would like to acknowledge UNC-CH Biobehavioral Laboratory for processing the hair cortisol samples. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIMHD or NIH.

Footnotes

This article is part of a special issue entitled: Menopause, Andropause, and Mental Health published in Comprehensive Psychoneuroendocrinology.

Appendix A

Supplementary data to this article can be found online at https://doi.org/10.1016/j.cpnec.2026.100359.

Appendix A. Supplementary data

The following is the Supplementary data to this article:

Multimedia component 1
mmc1.docx (935.7KB, docx)

References

  • 1.Wright K.D., Hickman R., Laudenslager M.L. Hair cortisol analysis: a promising biomarker of HPA activation in older adults. Gerontol. 2015;55(Suppl 1):S140–S145. doi: 10.1093/geront/gnu174. Suppl 1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Botschek T., Hußlein V., Peters E.M.J., Brosig B. Hair cortisol as outcome parameter for psychological and neuropsychiatric interventions-a literature review. Front. Psychiatr. 2023;14 doi: 10.3389/fpsyt.2023.1227153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gibson C.J., Thurston R.C., Matthews K.A. Cortisol dysregulation is associated with daily diary-reported hot flashes among midlife women. Clin Endocrinol (Oxf) 2016;85(4):645–651. doi: 10.1111/cen.13076. [DOI] [PubMed] [Google Scholar]
  • 4.Woods N.F., Mitchell E.S., Smith-Dijulio K. Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause. 2009;16(4):708–718. doi: 10.1097/gme.0b013e318198d6b2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Grub J., Süss H., Willi J., Ehlert U. Steroid hormone secretion over the course of the perimenopause: findings from the Swiss perimenopause study. Front Glob Womens Health. 2021;2 doi: 10.3389/fgwh.2021.774308. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Cohn A.Y., Grant L.K., Nathan M.D., Wiley A., Abramson M., Harder J.A., Crawford S., Klerman E.B., Scheer F., Kaiser U.B., Rahman S.A., Joffe H. Effects of sleep fragmentation and estradiol decline on cortisol in a human experimental model of menopause. J. Clin. Endocrinol. Metab. 2023;108(11):e1347–e1357. doi: 10.1210/clinem/dgad285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Chauntry A.J., Bishop N.C., Hamer M., Kingsnorth A.P., Chen Y.L., Paine N.J. Sedentary behaviour is associated with heightened cardiovascular, inflammatory and cortisol reactivity to acute psychological stress. Psychoneuroendocrinology. 2022;141 doi: 10.1016/j.psyneuen.2022.105756. [DOI] [PubMed] [Google Scholar]
  • 8.Hantsoo L., Jagodnik K.M., Novick A.M., Baweja R., di Scalea T.L., Ozerdem A., McGlade E.C., Simeonova D.I., Dekel S., Kornfield S.L., Nazareth M., Weiss S.J. The role of the hypothalamic-pituitary-adrenal axis in depression across the female reproductive lifecycle: current knowledge and future directions. Front Endocrinol (Lausanne) 2023;14 doi: 10.3389/fendo.2023.1295261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Knight J.M., Avery E.F., Janssen I., Powell L.H. Cortisol and depressive symptoms in a population-based cohort of midlife women. Psychosom. Med. 2010;72(9):855–861. doi: 10.1097/PSY.0b013e3181f4ab87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Lehrer H.M., Steinhardt M.A., Dubois S.K., Laudenslager M.L. Perceived stress, psychological resilience, hair cortisol concentration, and metabolic syndrome severity: a moderated mediation model. Psychoneuroendocrinology. 2020;113 doi: 10.1016/j.psyneuen.2019.104510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.van der Valk E., Abawi O., Mohseni M., Abdelmoumen A., Wester V., van der Voorn B., Iyer A., van den Akker E., Hoeks S., van den Berg S., de Rijke Y., Stalder T., van Rossum E. Cross-sectional relation of long-term glucocorticoids in hair with anthropometric measurements and their possible determinants: a systematic review and meta-analysis. Obes. Rev. 2022;23(3) doi: 10.1111/obr.13376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.van der Valk E.S., van der Voorn B., Iyer A.M., Mohseni M., Leenen P.J.M., Dik W.A., van den Berg S.A.A., de Rijke Y.B., van den Akker E.L.T., Penninx B., van Rossum E.F.C. Hair cortisol, obesity and the immune system: results from a 3 year longitudinal study. Psychoneuroendocrinology. 2021;134 doi: 10.1016/j.psyneuen.2021.105422. [DOI] [PubMed] [Google Scholar]
  • 13.Adam E.K., Quinn M.E., Tavernier R., McQuillan M.T., Dahlke K.A., Gilbert K.E. Diurnal cortisol slopes and mental and physical health outcomes: a systematic review and meta-analysis. Psychoneuroendocrinology. 2017;83:25–41. doi: 10.1016/j.psyneuen.2017.05.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Gerber L.M., Sievert L.L., Schwartz J.E. Hot flashes and midlife symptoms in relation to levels of salivary cortisol. Maturitas. 2017;96:26–32. doi: 10.1016/j.maturitas.2016.11.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Reed S.D., Newton K.M., Larson J.C., Booth-LaForce C., Woods N.F., Landis C.A., Tolentino E., Carpenter J.S., Freeman E.W., Joffe H., Anawalt B.D., Guthrie K.A. Daily salivary cortisol patterns in midlife women with hot flashes. Clin Endocrinol (Oxf) 2016;84(5):672–679. doi: 10.1111/cen.12995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sauer T., Tottenham L.S., Ethier A., Gordon J.L. Perimenopausal vasomotor symptoms and the cortisol awakening response. Menopause. 2020;27(11):1322–1327. doi: 10.1097/gme.0000000000001588. [DOI] [PubMed] [Google Scholar]
  • 17.Abell J.G., Stalder T., Ferrie J.E., Shipley M.J., Kirschbaum C., Kivimäki M., Kumari M. Assessing cortisol from hair samples in a large observational cohort: the whitehall II study. Psychoneuroendocrinology. 2016;73:148–156. doi: 10.1016/j.psyneuen.2016.07.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Herane-Vives A., Young A.H., Wise T., Aguirre J., de Angel V., Arnone D., Papadopoulos A., Cleare A.J. Comparison of short-term (saliva) and long-term (hair) cortisol levels in out-patients with melancholic and non-melancholic major depression. BJPsych Open. 2020;6(3) doi: 10.1192/bjo.2020.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Stalder T., Lupien S.J., Kudielka B.M., Adam E.K., Pruessner J.C., Wüst S., Dockray S., Smyth N., Evans P., Kirschbaum C., Miller R., Wetherell M.A., Finke J.B., Klucken T., Clow A. Evaluation and update of the expert consensus guidelines for the assessment of the cortisol awakening response (CAR) Psychoneuroendocrinology. 2022;146 doi: 10.1016/j.psyneuen.2022.105946. [DOI] [PubMed] [Google Scholar]
  • 20.Vignesh V., Castro-Dominguez B., James T.D., Gamble-Turner J.M., Lightman S., Reis N.M. Advancements in cortisol detection: from conventional methods to next-generation technologies for enhanced hormone monitoring. ACS Sens. 2024;9(4):1666–1681. doi: 10.1021/acssensors.3c01912. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Natarelli N., Gahoonia N., Sivamani R.K. Integrative and mechanistic approach to the hair growth cycle and hair loss. J. Clin. Med. 2023;12(3) doi: 10.3390/jcm12030893. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Brondolo E., Byer K., Gianaros P.J., Liu C., Prather A.A., Thomas K., Woods-Giscombé C.L. American Psychological Association; 2023. Stress in America: the State of our Nation.https://www.apa.org/pi/health-equity/resources/stress-report.pdf [Google Scholar]
  • 23.Cortés Y.I., Marginean V., Berry D. Physiologic and psychosocial changes of the menopause transition in US Latinas: a narrative review. Climacteric. 2021;24(3):214–228. doi: 10.1080/13697137.2020.1834529. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Ryan D., Tornberg-Belanger S.N., Perez G., Maurer S., Price C., Rao D., Chan K.C.G., Ornelas I.J. Stress, social support and their relationship to depression and anxiety among Latina immigrant women. J. Psychosom. Res. 2021;149 doi: 10.1016/j.jpsychores.2021.110588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Boileau K., Barbeau K., Sharma R., Bielajew C. Ethnic differences in diurnal cortisol profiles in healthy adults: a meta-analysis. Br. J. Health Psychol. 2019;24(4):806–827. doi: 10.1111/bjhp.12380. [DOI] [PubMed] [Google Scholar]
  • 26.DeSantis A.S., Adam E.K., Hawkley L.C., Kudielka B.M., Cacioppo J.T. Racial and ethnic differences in diurnal cortisol rhythms: are they consistent over time? Psychosom. Med. 2015;77(1):6–15. doi: 10.1097/psy.0000000000000131. [DOI] [PubMed] [Google Scholar]
  • 27.Farabi S.S., Schwarz C., Persaud A., Gilbert A., Haire-Joshu D., Tabak R.G. Sleep, stress, and cardiometabolic health in women of childbearing age with overweight and obesity. Womens Health Rep (New Rochelle) 2024;5(1):143–151. doi: 10.1089/whr.2023.0138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Reducing Cardiovascular Disease Risk in Perimenopausal Latinas . 2020. Pilot Study of a Multi-Component Intervention.https://clinicaltrials.gov/study/NCT04313751 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Balcazar H., Fernandez Gaxiola A., Pérez-Lizaur A., Peyron R., Ayala C. Improving Heart Healthy Lifestyles Among Participants in a Salud Para Su Corazón Promotores Model: the Mexican Pilot Study. Prev. Chronic Dis. 2015;12:2009–2012. doi: 10.5888/pcd12.140292. E34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Balcázar H.G., de Heer H., Rosenthal L., Aguirre M., Flores L., Puentes F.A., Cardenas V.M., Duarte M.O., Ortiz M., Schulz L.O. A promotores de salud intervention to reduce cardiovascular disease risk in a high-risk Hispanic border population, 2005-2008. Prev. Chronic Dis. 2010;7(2) [PMC free article] [PubMed] [Google Scholar]
  • 31.Fort M.P., Murillo S., López E., Dengo A.L., Alvarado-Molina N., de Beausset I., Castro M., Peña L., Ramírez-Zea M., Martínez H. Impact evaluation of a healthy lifestyle intervention to reduce cardiovascular disease risk in health centers in San José, Costa Rica and Chiapas, Mexico. BMC Health Serv. Res. 2015;15:577. doi: 10.1186/s12913-015-1248-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Hoos T., Espinoza N., Marshall S., Arredondo E.M. Validity of the Global Physical Activity Questionnaire (GPAQ) in adult Latinas. J. Phys. Activ. Health. 2012;9(5):698–705. doi: 10.1123/jpah.9.5.698. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Koniak-Griffin D., Brecht M.L., Takayanagi S., Villegas J., Melendrez M., Balcázar H. A community health worker-led lifestyle behavior intervention for Latina (Hispanic) women: feasibility and outcomes of a randomized controlled trial. Int. J. Nurs. Stud. 2015;52(1):75–87. doi: 10.1016/j.ijnurstu.2014.09.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Morgan A.L., Tobar D.A., Snyder L. Walking toward a new me: the impact of prescribed walking 10,000 steps/day on physical and psychological well-being. J. Phys. Activ. Health. 2010;7(3):299–307. doi: 10.1123/jpah.7.3.299. [DOI] [PubMed] [Google Scholar]
  • 35.Berry D., Colindres M., Lugo-Sanchez L., Sanchez M., Neal M., Smith-Miller C. Adapting, feasibility testing, and pilot testing a weight management intervention for recently immigrated spanish-speaking women and their 2- to 4-Year-Old children. Hisp. Health Care Int. 2011;9:186–193. doi: 10.1891/1540-4153.9.4.186. [DOI] [Google Scholar]
  • 36.Cortés Y.I., Duran M., Marginean V., Harris L.K., Cazales A., Santiago L., Mislan M.D., Perreira K.M. Lessons learned in clinical research recruitment of midlife latinas during COVID-19. Menopause. 2022;29(7):883–888. doi: 10.1097/gme.0000000000001983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Martins-Silva T., Martins R.C., Murray J., Carvalho A.M., Rickes L.N., Corrêa B.F., Fraga B.B., Brum C.B., Freitas D.F., Meyer F.D.T., Carpena M.X., Goularte L.M., Gonzalez A., Oliveira I.O., Tovo-Rodrigues L. Hair cortisol measurement: a systematic review of current practices and a proposed checklist for reporting standards. Psychoneuroendocrinology. 2025;171 doi: 10.1016/j.psyneuen.2024.107185. [DOI] [PubMed] [Google Scholar]
  • 38.#1-3002, S. A. Salivary cortisol - enzyme Immunoassay Kit. Salimetrics. 2024, August 9, 2024 https://salimetrics.com/wp-content/uploads/2018/03/1-3002b-cortisol-ruo.pdf Retrieved January 31, 2025 from. [Google Scholar]
  • 39.Ingram P.B.t., Clarke E., Lichtenberg J.W. Confirmatory factor analysis of the perceived stress Scale-4 in a community sample. Stress Health. 2016;32(2):173–176. doi: 10.1002/smi.2592. [DOI] [PubMed] [Google Scholar]
  • 40.Berenbon R.F. Using Rasch analysis to investigate the validity of the Everyday Discrimination Scale in a national sample. J. Health Psychol. 2020;25(13–14):2388–2395. doi: 10.1177/1359105318800788. [DOI] [PubMed] [Google Scholar]
  • 41.Rodríguez-Rey R., Alonso-Tapia J., Hernansaiz-Garrido H. Reliability and validity of the Brief Resilience Scale (BRS) Spanish Version. Psychol. Assess. 2016;28(5):e101–e110. doi: 10.1037/pas0000191. [DOI] [PubMed] [Google Scholar]
  • 42.Vallejo M.A., Vallejo-Slocker L., Fernández-Abascal E.G., Mañanes G. Determining factors for stress perception assessed with the Perceived Stress Scale (PSS-4) in Spanish and other European samples. Front. Psychol. 2018;9:37. doi: 10.3389/fpsyg.2018.00037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Michaels E., Thomas M., Reeves A., Price M., Hasson R., Chae D., Allen A. Coding the Everyday Discrimination Scale: implications for exposure assessment and associations with hypertension and depression among a cross section of mid-life African American women. J. Epidemiol. Community Health. 2019;73(6):577–584. doi: 10.1136/jech-2018-211230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Rodriguez C.J., Allison M., Daviglus M.L., Isasi C.R., Keller C., Leira E.C., Palaniappan L., Piña I.L., Ramirez S.M., Rodriguez B., Sims M. Status of cardiovascular disease and stroke in Hispanics/Latinos in the United States: a science advisory from the American Heart Association. Circulation. 2014;130(7):593–625. doi: 10.1161/cir.0000000000000071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Green R., Santoro N. Menopausal symptoms and ethnicity: the Study of Women's Health across the nation. Womens Health (Lond) 2009;5(2):127–133. doi: 10.2217/17455057.5.2.127. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Shahid A., Wilkinson K., Marcu S., Shapiro C. STOP, THAT and one hundred other sleep scales. 2012. [DOI]
  • 47.Croft J.B., Keenan N.L., Sheridan D.P., Wheeler F.C., Speers M.A. Waist-to-hip ratio in a biracial population: measurement, implications, and cautions for using guidelines to define high risk for cardiovascular disease. J. Am. Diet. Assoc. 1995;95(1):60–64. doi: 10.1016/s0002-8223(95)00014-3. [DOI] [PubMed] [Google Scholar]
  • 48.Prevention T. The Centers for Disease Control and Prevention; 2024. Adult BMI Categories.https://www.cdc.gov/bmi/adult-calculator/bmi-categories.html Retrieved January 31, 2025 from. [Google Scholar]
  • 49.Cagnacci A., Cannoletta M., Caretto S., Zanin R., Xholli A., Volpe A. Increased cortisol level: a possible link between climacteric symptoms and cardiovascular risk factors. Menopause. 2011;18(3):273–278. doi: 10.1097/gme.0b013e3181f31947. [DOI] [PubMed] [Google Scholar]
  • 50.Deecher D.C., Dorries K. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages. Arch Womens Ment Health. 2007;10(6):247–257. doi: 10.1007/s00737-007-0209-5. [DOI] [PubMed] [Google Scholar]
  • 51.Lynch R., Flores-Torres M.H., Hinojosa G., Aspelund T., Hauksdóttir A., Kirschbaum C., Catzin-Kuhlmann A., Lajous M., Valdimarsdottir U. Perceived stress and hair cortisol concentration in a study of Mexican and Icelandic women. PLOS Glob. Publ. Health. 2022;2(8) doi: 10.1371/journal.pgph.0000571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.O'Brien K.M., Tronick E.Z., Moore C.L. Relationship between hair cortisol and perceived chronic stress in a diverse sample. Stress Health. 2013;29(4):337–344. doi: 10.1002/smi.2475. [DOI] [PubMed] [Google Scholar]
  • 53.Vargas S.M., Parra L.A., Yu S.H., Flores A., Rivas W.A., Payat S., Mistry R., Griffith K., Williams C.R., Gamez D., Saxbe D., Huey S.J., Jr., Lau A., Chung B., Miranda J. How intersectional identity and discrimination contribute to depressive symptoms and hair cortisol concentrations among low-income, racially and sexual diverse adults. Psychoneuroendocrinology. 2025;176 doi: 10.1016/j.psyneuen.2025.107429. [DOI] [PubMed] [Google Scholar]
  • 54.Moody S.N., van Dammen L., Wang W., Greder K.A., Neiderhiser J.M., Afulani P.A., Willette A., Shirtcliff E.A. Impact of hair type, hair sample weight, external hair exposures, and race on cumulative hair cortisol. Psychoneuroendocrinology. 2022;142 doi: 10.1016/j.psyneuen.2022.105805. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Wosu A.C., Valdimarsdóttir U., Shields A.E., Williams D.R., Williams M.A. Correlates of cortisol in human hair: implications for epidemiologic studies on health effects of chronic stress. Ann. Epidemiol. 2013;23(12):797–811.e792. doi: 10.1016/j.annepidem.2013.09.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Dettenborn L., Tietze A., Kirschbaum C., Stalder T. The assessment of cortisol in human hair: associations with sociodemographic variables and potential confounders. Stress. 2012;15(6):578–588. doi: 10.3109/10253890.2012.654479. [DOI] [PubMed] [Google Scholar]
  • 57.Igboanugo S., O'Connor C., Zitoun O.A., Ramezan R., Mielke J.G. A systematic review of hair cortisol in healthy adults measured using immunoassays: methodological considerations and proposed reference values for research. Psychophysiology. 2024;61(1) doi: 10.1111/psyp.14474. [DOI] [PubMed] [Google Scholar]
  • 58.Abelson J.L., Khan S., Giordano G.N., Stalder T. Does hair cortisol concentration reflect measurable regulatory biology of the HPA axis in healthy humans? Psychoneuroendocrinology. 2026;187 doi: 10.1016/j.psyneuen.2026.107778. [DOI] [PubMed] [Google Scholar]
  • 59.Yang H.Z., Lan J., Meng Y.J., Wan X.J., Han D.W. A preliminary study of steroid reproductive hormones in human hair. J. Steroid Biochem. Mol. Biol. 1998;67(5–6):447–450. doi: 10.1016/s0960-0760(98)00120-4. [DOI] [PubMed] [Google Scholar]
  • 60.Huthsteiner K., Finke J.B., Peters E.M.J., Kleinke K., Klucken T., Stalder T. What is the best sampling region for endocrine hair analysis? A comparison between the posterior vertex and occipital region and recommendation for standardization. Psychoneuroendocrinology. 2025;177 doi: 10.1016/j.psyneuen.2025.107457. [DOI] [PubMed] [Google Scholar]
  • 61.Genther D.J., Laudenslager M.L., Sung Y.K., Blake C.R., Chen D.S., Lin F.R. Assessing systemic stress in otolaryngology: methodology and feasibility of hair and salivary cortisol testing. J. Nat. Sci. 2015;1(8) [PMC free article] [PubMed] [Google Scholar]
  • 62.Samir S. Relationship between salivary cortisol, self-assessed stress levels, and body mass index in high achieving high school adolescents. Elements. 2018;14 doi: 10.6017/eurj.v14i1.10332. [DOI] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Multimedia component 1
mmc1.docx (935.7KB, docx)

Articles from Comprehensive Psychoneuroendocrinology are provided here courtesy of Elsevier

RESOURCES